Chinese General Practice ›› 2022, Vol. 25 ›› Issue (19): 2356-2362.DOI: 10.12114/j.issn.1007-9572.2022.0116
• Original Research·Clinical Quality Improvement • Previous Articles Next Articles
Received:
2022-02-22
Revised:
2022-05-22
Published:
2022-07-05
Online:
2022-06-02
Contact:
Zhenqiang REN
About author:
通讯作者:
任振强
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0116
基线资料 | PSM前 | PSM后 | |||||||
---|---|---|---|---|---|---|---|---|---|
已婚(n=2 357) | 非已婚(n=1 636) | χ2值 | P值 | 已婚(n=1 507) | 非已婚(n=1 507) | χ2值 | P值 | ||
确诊年龄(岁) | 57.21 | <0.001 | 0.84 | 0.360 | |||||
18~59 | 842(35.72) | 780(47.68) | 671(44.53) | 696(46.18) | |||||
≥60 | 1 515(64.28) | 856(52.32) | 836(55.47) | 811(53.82) | |||||
种族 | 5.77 | 0.016 | 0.72 | 0.396 | |||||
白种人 | 1 906(80.87) | 1 272(77.75) | 1 199(79.56) | 1 180(78.30) | |||||
其他 | 451(19.13) | 364(22.25) | 308(20.44) | 327(21.70) | |||||
性别 | 52.31 | <0.001 | 3.20 | 0.073 | |||||
男 | 1 353(57.40) | 749(45.78) | 673(44.66) | 722(47.91) | |||||
女 | 1 004(42.60) | 887(54.22) | 834(55.34) | 785(52.09) | |||||
确诊年份(年) | 2.03 | 0.154 | 0.97 | 0.325 | |||||
2000—2008 | 1 172(49.72) | 851(52.02) | 788(52.29) | 761(50.50) | |||||
2009—2016 | 1 185(50.28) | 785(47.98) | 719(47.71) | 746(49.50) | |||||
病理类型 | 2.95 | 0.086 | 0.65 | 0.421 | |||||
DLBCL | 1 898(80.53) | 1 281(78.30) | 1 181(78.37) | 1 199(79.56) | |||||
其他 | 459(19.47) | 355(21.70) | 326(21.63) | 308(20.44) | |||||
肿瘤位置 | 8.08 | 0.044 | 4.85 | 0.183 | |||||
脑脊膜 | 27(1.15) | 22(1.3) | 22(1.46) | 20(1.33) | |||||
脑 | 1 964(83.33) | 1 370(83.7) | 1 254(83.21) | 1 249(82.87) | |||||
脊髓 | 116(4.92) | 104(6.4) | 73(4.84) | 98(6.50) | |||||
其他 | 250(10.60) | 140(8.6) | 158(10.49) | 140(9.30) | |||||
手术 | 6.20 | 0.013 | 0.14 | 0.712 | |||||
否 | 1 304(55.32) | 970(59.29) | 869(57.66) | 879(58.33) | |||||
是 | 1 053(44.68) | 666(40.71) | 638(42.34) | 628(41.67) | |||||
放疗 | 0.02 | 0.892 | 0.58 | 0.446 | |||||
否 | 1 522(64.57) | 1 053(64.36) | 962(63.84) | 982(65.16) | |||||
是 | 835(35.43) | 583(35.64) | 545(36.16) | 525(34.84) | |||||
化疗 | 50.23 | <0.001 | 0.84 | 0.359 | |||||
否 | 671(28.47) | 641(39.18) | 513(34.04) | 537(35.63) | |||||
是 | 1 686(71.53) | 995(60.82) | 994(65.96) | 970(64.37) |
Table 1 Comparison of baseline characteristics between married and single primary central nervous system lymphoma patients before and after propensity score matching
基线资料 | PSM前 | PSM后 | |||||||
---|---|---|---|---|---|---|---|---|---|
已婚(n=2 357) | 非已婚(n=1 636) | χ2值 | P值 | 已婚(n=1 507) | 非已婚(n=1 507) | χ2值 | P值 | ||
确诊年龄(岁) | 57.21 | <0.001 | 0.84 | 0.360 | |||||
18~59 | 842(35.72) | 780(47.68) | 671(44.53) | 696(46.18) | |||||
≥60 | 1 515(64.28) | 856(52.32) | 836(55.47) | 811(53.82) | |||||
种族 | 5.77 | 0.016 | 0.72 | 0.396 | |||||
白种人 | 1 906(80.87) | 1 272(77.75) | 1 199(79.56) | 1 180(78.30) | |||||
其他 | 451(19.13) | 364(22.25) | 308(20.44) | 327(21.70) | |||||
性别 | 52.31 | <0.001 | 3.20 | 0.073 | |||||
男 | 1 353(57.40) | 749(45.78) | 673(44.66) | 722(47.91) | |||||
女 | 1 004(42.60) | 887(54.22) | 834(55.34) | 785(52.09) | |||||
确诊年份(年) | 2.03 | 0.154 | 0.97 | 0.325 | |||||
2000—2008 | 1 172(49.72) | 851(52.02) | 788(52.29) | 761(50.50) | |||||
2009—2016 | 1 185(50.28) | 785(47.98) | 719(47.71) | 746(49.50) | |||||
病理类型 | 2.95 | 0.086 | 0.65 | 0.421 | |||||
DLBCL | 1 898(80.53) | 1 281(78.30) | 1 181(78.37) | 1 199(79.56) | |||||
其他 | 459(19.47) | 355(21.70) | 326(21.63) | 308(20.44) | |||||
肿瘤位置 | 8.08 | 0.044 | 4.85 | 0.183 | |||||
脑脊膜 | 27(1.15) | 22(1.3) | 22(1.46) | 20(1.33) | |||||
脑 | 1 964(83.33) | 1 370(83.7) | 1 254(83.21) | 1 249(82.87) | |||||
脊髓 | 116(4.92) | 104(6.4) | 73(4.84) | 98(6.50) | |||||
其他 | 250(10.60) | 140(8.6) | 158(10.49) | 140(9.30) | |||||
手术 | 6.20 | 0.013 | 0.14 | 0.712 | |||||
否 | 1 304(55.32) | 970(59.29) | 869(57.66) | 879(58.33) | |||||
是 | 1 053(44.68) | 666(40.71) | 638(42.34) | 628(41.67) | |||||
放疗 | 0.02 | 0.892 | 0.58 | 0.446 | |||||
否 | 1 522(64.57) | 1 053(64.36) | 962(63.84) | 982(65.16) | |||||
是 | 835(35.43) | 583(35.64) | 545(36.16) | 525(34.84) | |||||
化疗 | 50.23 | <0.001 | 0.84 | 0.359 | |||||
否 | 671(28.47) | 641(39.18) | 513(34.04) | 537(35.63) | |||||
是 | 1 686(71.53) | 995(60.82) | 994(65.96) | 970(64.37) |
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | ||||||
---|---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | |||
PSM前 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.18(1.09,1.27) | 17.03 | <0.001 | 1.23(1.14,1.33) | 26.21 | <0.001 | ||
PSM后 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.19(1.09,1.30) | 15.06 | <0.001 | 1.24(1.14,1.36) | 23.32 | <0.001 |
Table 2 Univariate and multivariate Cox regression analyses of the influence of marital status on overall survival in patients with primary central nervous system lymphoma
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | ||||||
---|---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | |||
PSM前 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.18(1.09,1.27) | 17.03 | <0.001 | 1.23(1.14,1.33) | 26.21 | <0.001 | ||
PSM后 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.19(1.09,1.30) | 15.06 | <0.001 | 1.24(1.14,1.36) | 23.32 | <0.001 |
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | ||||||
---|---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | |||
PSM前 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.17(1.08,1.27) | 14.45 | <0.001 | 1.21(1.11,1.31) | 18.57 | <0.001 | ||
PSM后 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.18(1.08,1.29) | 11.74 | <0.001 | 1.22(1.11,1.33) | 16.45 | <0.001 |
Table 3 Univariate and multivariate Cox regression analyses of the influence of marital status on cancer-specific survival in patients with primary central nervous system lymphoma
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | ||||||
---|---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | |||
PSM前 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.17(1.08,1.27) | 14.45 | <0.001 | 1.21(1.11,1.31) | 18.57 | <0.001 | ||
PSM后 | ||||||||
婚姻状态(以非已婚为参照) | ||||||||
已婚 | 1.18(1.08,1.29) | 11.74 | <0.001 | 1.22(1.11,1.33) | 16.45 | <0.001 |
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | |||||
---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | ||
婚姻状态(以已婚为参照) | |||||||
单身 | 0.96(0.87,1.07) | 0.52 | 0.473 | 1.14(1.03,1.27) | 6.20 | 0.013 | |
离异 | 1.13(0.99,1.30) | 3.20 | 0.074 | 1.23(1.07,1.41) | 8.39 | 0.004 | |
丧偶 | 1.75(1.56,1.96) | 94.42 | <0.001 | 1.37(1.21,1.54) | 26.07 | <0.001 |
Table 4 Univariate and multivariate Cox regression analyses of the influence of different marital status on overall survival in patients with primary central nervous system lymphoma
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | |||||
---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | ||
婚姻状态(以已婚为参照) | |||||||
单身 | 0.96(0.87,1.07) | 0.52 | 0.473 | 1.14(1.03,1.27) | 6.20 | 0.013 | |
离异 | 1.13(0.99,1.30) | 3.20 | 0.074 | 1.23(1.07,1.41) | 8.39 | 0.004 | |
丧偶 | 1.75(1.56,1.96) | 94.42 | <0.001 | 1.37(1.21,1.54) | 26.07 | <0.001 |
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | |||||
---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | ||
婚姻状态(以已婚为参照) | |||||||
单身 | 1.00(0.90,1.12) | 0.06 | 0.940 | 1.15(1.03,1.29) | 6.24 | 0.012 | |
离异 | 1.14(0.98,1.31) | 2.94 | 0.086 | 1.22(1.05,1.41) | 6.86 | 0.009 | |
丧偶 | 1.63(1.44,1.84) | 59.21 | <0.001 | 1.28(1.12,1.46) | 13.42 | <0.001 |
Table 5 Univariate and multivariate Cox regression analyses of the influence of different marital status on cancer-specific survival in patients with primary central nervous system lymphoma
自变量 | 单因素Cox回归分析 | 多因素Cox回归分析 | |||||
---|---|---|---|---|---|---|---|
HR(95%CI) | χ2值 | P值 | HR(95%CI) | χ2值 | P值 | ||
婚姻状态(以已婚为参照) | |||||||
单身 | 1.00(0.90,1.12) | 0.06 | 0.940 | 1.15(1.03,1.29) | 6.24 | 0.012 | |
离异 | 1.14(0.98,1.31) | 2.94 | 0.086 | 1.22(1.05,1.41) | 6.86 | 0.009 | |
丧偶 | 1.63(1.44,1.84) | 59.21 | <0.001 | 1.28(1.12,1.46) | 13.42 | <0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
秦玲玲,陈莺,苏淼,等. 婚姻状态对颊黏膜鳞癌患者生存的影响[J]. 口腔疾病防治,2020,28(11):718-722. DOI:10.12016/j.issn.2096-1456.2020.11.007.
|
[12] |
杨传维,任晓辉,蒋海辉,等. 基于SEER数据库的原发性中枢神经系统淋巴瘤不同治疗方法的疗效分析[J]. 中华外科杂志,2021,59(1):51-57. DOI:10.3760/cma.j.cn112139-20200831-00673.
|
[13] |
卢婕伦,黎波,吴泽霖,等. 基于SEER数据库分析伯基特白血病的预后影响因素[J]. 实用医学杂志,2019,35(15):2478-2481. DOI:10.3969/j.issn.1006-5725.2019.15.027.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
蔡静静,肖寿勇,吴茂芳,等. 辅助化疗在完全性切除IB期非小细胞肺癌患者中的倾向匹配分析[J]. 临床肿瘤学杂志,2020,25(7):601-608.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[1] | Yan LI, Kunlun WANG, Hui YANG, Erjiang ZHAO, Bingxu LI, Shenglei LI, Xiaotao DONG, Ling YUAN. Prognostic Value of Lactate Dehydrogenase in Advanced Esophageal Squamous Cell Carcinoma Patients with Immunotherapy [J]. Chinese General Practice, 2022, 25(26): 3263-3269. |
[2] | WU Wenxia,ZHANG Meng. Study on the Effect of Baseline Blood Lipid Level on the Prognosis of Patients with Non-triple-negative Breast Cancer [J]. Chinese General Practice, 2021, 24(26): 3316-3322. |
[3] | CAI Menghui,LIU Feng,GE Tianyu,FENG Zihao,HUANG Kunping,GE Bo. Prognostic Value of Partial Ephrectomy in Patients with Localized Ⅰ Clear Cell Renal Cell Carcinoma [J]. Chinese General Practice, 2021, 24(20): 2555-2562. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||